Marcela V. Maus, M.d.,ph.d.

This early-stage study is testing a new type of cell therapy called CC-97540 for people with a severe autoimmune disease called ANCA-associated vasculitis that has come back or hasn't responded to standard treatments. The main goals are to check if the treatment is safe and to se…